Minimizing Risk and Maximizing Insight: A Conversation on AI in Market Research
Minimizing Risk and Maximizing Insight: A Conversation on AI in Market Research AI is reshaping market research and consulting—improving hypothesis […]
Humanizing AI to Improve Market Research Outcomes
Market research teams are under more pressure than ever. Timelines are shrinking. Budgets are tightening. Expectations for certainty keep rising
The Emerging Innovative Pharmaceutical Enterprises in China
Building on the China Pharmaceutical Innovation and Invention Index, which assesses the overall innovation strength of leading Chinese pharmaceutical companies, here
Fulcrum Research Group and Synthetic Users
What it is: Synthetic Users built for pharma research: AI that behaves like real, emotional respondents. Exclusive to Fulcrum Research and SAI.
Revitalizing Pharma Collaborations: The Reblozyl Case Study
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the
Pioneering the Future of Cardiovascular Treatment with Sekar Kathiresan
In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about
Decision Frameworks in Pharma: From RAVE and DICE to Lilly’s Truth-Seeking Machine
What Works, What Kills What, and Why It Matters By Mike Rea In pharmaceutical R&D, where billions ride on the
2025 Collaborating for Novel Solutions (CNS) Summit: Annual Pharma Digital Innovation Index, cements leaders in the Biopharmaceutical innovation of digital solutions.
Tuesday, November 4th, 2025, Boston, MA – Today, the annual Pharmaceutical Digital Innovation Index, a partnership between IDEA Pharma, a